DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundationGP

Structural and non-structural causes of bleeding

Essential points for quick revision.

!
Classification follows stabilisation

Haemodynamic compromise, pregnancy-related bleeding, severe anaemia, sepsis, torsion or uncontrolled loss requires acute management before a detailed PALM-COEIN classification is completed.

Action: Resuscitate, test for pregnancy, obtain urgent bloods and senior gynaecology input, then use examination and imaging to identify the bleeding source and definitive control.

Synopsis

Organise abnormal uterine bleeding into structural and non-structural mechanisms, use pattern and risk to select imaging or hysteroscopy, and recognise when more than one cause is contributing.

  • PALM describes structural causes: polyp, adenomyosis, leiomyoma, and malignancy or hyperplasia; COEIN describes coagulopathy, ovulatory dysfunction, endometrial dysfunction, iatrogenic causes and causes not otherwise classified.
  • The framework organises mechanisms rather than declaring one final diagnosis; fibroids and anticoagulation, adenomyosis and anovulation, or a polyp and hormonal contraception can coexist.
  • Pregnancy-related, cervical, vaginal, vulval, urinary and rectal bleeding sit outside non-pregnant uterine classification and must be localised first.

Key red flags

Postmenopausal bleeding, persistent intermenstrual bleeding, suspicious cervix, new pelvic mass or unexplained weight loss requires prompt cancer-pathway assessment.

Investigation priorities

01
Pregnancy testing and source localisationFirst step

Remove pregnancy-related and non-uterine bleeding from the classification before uterine testing.

Management branches

Classify patternSeparate source, timing and mechanism

Bleeding is heavy, irregular, intermenstrual, postcoital or prolonged.

  1. Establish pregnancy status and anatomical source, then describe cycle regularity, duration, volume impact, pain and non-menstrual bleeding.
  2. Review pelvic symptoms, examination, bleeding history, endocrine phenotype and treatment exposure to populate plausible PALM and COEIN categories.
Open full textbook Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom